Eye-opening care. Life-changing results. Far-reaching implications.
At Chu Vision, we help patients move forward with confidence by providing clear, concise information upfront and kind, considerate care throughout. We are also committed to advancing the field of eye care. Learn more about how we have taken a leadership role within our professional community—locally and globally—to help bring leading-edge technologies to market.
Current Clinical Trials

Glaukos iDose

If you have been diagnosed with mild to moderate open-angle glaucoma and are currently taking up to three anti-glaucoma medications, you may be eligible to participate in a research study.

Dr. Ralph Chu is currently participating in a research study to evaluate a product called Travoprost Intraocular Implant for patients with glaucoma, designed to reduce eye pressure by delivering glaucoma medications slowly into your eye over time.

For more information or to set up an appointment, please call 952-835-1235 or email nic.jacobs@chuvision.com.

To learn more visit www.GlaukosClinicalTrials.com.

Nic JacobsVP Clinical Research and Regulatory
nic.jacobs@chuvision.com
Local | 952.835.1235
Toll-free | 866.400.EYES




 
 

Cord IOL

older couple on computer

Are you in need of cataract surgery? Are you looking for a solution that may also eliminate or reduce your need for glasses?

Dr. Ralph Chu is currently participating in a research study to evaluate an investigational intraocular lens (IOL) for patients with cataracts.

If you have cataracts, you may be eligible to participate in this research study.

Now is a great time to come in for an evaluation. For more information or to set up an appointment, please call 952-835-1235 or email nic.jacobs@chuvision.com

 
You may be a candidate if: 
  • You have cataracts in both eyes
  • You are 22 years or older
  • You have had no previous eye surgeries
  • You have no ocular health issues other than cataracts (i.e. glaucoma, macular degeneration)
  • You have no systemic health issues or autoimmune conditions
  • You are not taking certain medications such as flomax. 
To learn more about the Cord IOL click here.


IC-8 IOL
Seeking Participants for a Clinical Study for Cataract Patients

We are excited to be clinical investigators for the IC-8 lens clinical study. The clinical study is designed to evaluate if the IC-8 lens will provide far, intermediate and near vision for patients with cataracts.

The IC-8 lens is a clear monofocal lens with a mini-ring placed in the center. The mini-ring has an opening, or pinhole, designed to increase the range of vision by extending the focus of light rays that enter the eye.



There are two ways you may be able to participate in the clinical study:

  1. Test Group (IC-8 Lens Group) will have a standard monofocal lens implanted in the first eye. If visual requirements are met after the first lens is implanted, the IC-8lens will be implanted into the other eye. The IC-8 lens is an investigational device and is being studied to determine if vision at all distances is clearer than with a standard monofocal lens in both eyes.
  2. Control Group (Monofocal Lens Group) will have a standard monofocal lens implanted in the first eye. If visual requirements are met, a standard monofocal lens will be implanted in the other eye.A standard monofocal lens is designed to provide far vision, but not near or intermediate vision.

Comparison of the two groups will help determine the improvement in vision with the IC-8 lens. Patients who participate in either group and comply with study commitments will be compensated.

If you would like to become a volunteer participant, the first step is to contact us to set up an eye examination. Please call 952-835-1235.  Click here for more information about the clinical study: www.ic8lensclinicalstudy.com.

Caution: Investigational Device. Limited by Federal (or United States) law to investigational use.


Envista Trifocal IOL

envista web

ORASIS

Join our upcoming study for people ages 45-64 who wear reading glasses!

Presbyopia is a very common condition that occurs after age 40 and symptoms can include blurred vision at near distances or difficulty seeing things close-up. People with presbyopia often have trouble when performing daily tasks such as reading a book, restaurant menu or messages on a smartphone.

Starting soon, Dr. Chu will be conducting a new research study to evaluate how effective an investigational eyedrop is at treating presbyopia. If you are between the ages of 45 and 64 years old and have difficulty reading things close up, we invite you to participate.

The study involves 4 office visits over the course of 2-4 weeks. If you complete these office visits, you may be compensated up to $1,200 for your time.

For more information, please contact Nic Jacobs at 952-835-1235 or nic.jacobs@chuvision.com.